login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 
Portable electric device found to slow and reverse growth of glioblastoma
Friday, 21 Nov 2014
A non-invasive, portable electrical device has been found to lengthen the lives of some patients suffering from glioblastoma, the most common and deadliest form of brain cancer. Portable electric device found to slow and reverse growth of glioblastoma

Friday, 21 Nov 2014
Performed last month, the surgery involves inserting a bioresorbable scaffolding implant to act as a bridge across the gap of the injured section of the cord in an attempt to help the spinal cord heal. Barrow neurosurgeons implant the world’s first scaffold into a patient’s spinal cord

More news

VIDEOS

Insights from Michael Söderman on world’s first Philips NeuroSuite installation

Karolinska University Hospital has the world’s first Philips NeuroSuite with the unique AlluraClarity FD20/15 interventional X-ray system. Michael Söderman reports that this new system has the perfect combination of Flat Detectors to see exactly what you want to see and to avoid collisions.

More videos

PROFILES

Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

More profiles

Jeffrey Saver and Tudor Jovin

MR CLEAN: Expert opinion

Jeffrey Saver, Tudor Jovin and others discuss the trial that has sent a ripple across the entire neurointerventional arena.

OPINION

EVENTS

The changing face of traumatic brain injury: Life beyond the guidelines András Büki and Andrew Maas write that despite considerable efforts both in basic and clinical research, there has not been a major breakthrough in the care of the head injured in the last three ... The changing face of traumatic brain injury: Life beyond the guidelines

Neuro-oncologic treatment for glioblastoma Malignant gliomas are the most common type of primary malignant brain tumour, accounting for 80% of patients and an annual incidence of 5.26 per 100,000 population, or 17,000 new cases diagnosed per ... Neuro-oncologic treatment for glioblastoma







Vercise deep brain stimulation system
Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions